
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A leading academic institution in Oxford seeks a researcher to join a multidisciplinary team focused on immune cell research in multiple sclerosis (MS). The role requires a PhD in Immunology and experience with immune cell-based assays. You will collaborate internationally and develop innovative research techniques. This position offers a range of benefits including generous leave and a pension scheme.
Translational Immunology Development Unit (TIDU), Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford. You are invited to apply to join Professor Lars Fugger and a multidisciplinary research team at the MRC Translational Discovery Immunology Unit, based at the Weatherall Institute of Molecular Medicine. You will join research scientists, computational biologists, and clinicians, have access to state-of-the-art technologies and collaborate with leading researchers both locally and internationally. This research project aims to explore the role of immune cells in autoimmune, demyelinating diseases of the central nervous system, with an emphasis on patients with multiple sclerosis (MS). The work uses innovative laboratory and analytical techniques to expose new disease-associated immune cell populations that explain why environmental context is critical to disease cause and to explore how the immune system contributes to disease progression. The aim is for the research to be clinically translatable and to support drug development.
If you would like to discuss your application informally before applying, please email Professor Fugger (lars.fugger@imm.ox.ac.uk). Further information regarding the research group of Professors Lars Fugger can be found at: https://www.imm.ox.ac.uk/research/research-groups/fugger-group
The Radcliffe Department of Medicine (RDM) within the Medical Sciences Division is one of the largest departments in the University of Oxford. RDM is a multi-disciplinary department which aims to tackle some of the world\'s biggest health challenges by integrating innovative basic biology with cutting edge clinical research.